Hi Dan,
INMETRO is a Brazilian accreditation entity while ANVISA is Brazil's regulatory body for products and services subject to health regulation. The relationship between the two can be better understood by reviewing RDC 549 and Ordinance 384/2020, but to summarize INMETRO can accredit certification organizations who in turn are responsible for certifying products for compliance with the Brazilian Conformity Assessment System (SBAC). For applicable devices, this certification will be a necessary part of the registration application reviewed by ANVISA, but the certification alone does not grant a medical device entrance to the Brazilian market.
If you will require INMETRO certification then I strongly recommend reviewing Ordinance 384/2020 as this is what the product will be certified to.
------------------------------
Ian Boland, RAC
Regulatory Affairs Specialist
NJ
United States
------------------------------
Original Message:
Sent: 26-Sep-2023 13:43
From: Dan O'Leary
Subject: Standards / Regulations - Brazil
I noticed these are all ANVISA. How does INMETRO fit into the Brazilian system? Is there a similar list for INMETRO regulations?
------------------------------
Dan O'Leary CQA, CQE
Swanzey NH
United States
Original Message:
Sent: 08-Jun-2023 09:21
From: Guillermo Heer
Subject: Standards / Regulations - Brazil
Hello,
There are several RDCs issued in the last years, the most relevant ones are the RDC 665/2022 (requirements for Brazilian GMP) and the RDC 751/2022 (requirements for notification and registration of medical devices). Then, there are many other RDC related to both products and companies, for example:
RDC 67/2009 Provisions regarding post-market surveillance.
RDC 551/2021 Provides for the mandatory execution and notification of field actions by health product registration holders in Brazil.
RDC 687/2022 Provides criteria for the issuance and renewal of Brazilian GMP.
RDC 431/2020 Requirements for registration holders to upload the Instructions for Use (IFU) for registered medical devices to ANVISA's electronic portal.
RDC 340/2020 Establishes Rules for Post-approval Modifications.
RDC 591/2021 Establishes a globally harmonized Unique Device Identification (UDI).
Among other RDCs that may be applicable depending on the type of products you commercialise.
Best regards,
Guillermo
------------------------------
Guillermo Heer
Biomedical Engineer
Esperanza
Argentina
Original Message:
Sent: 07-Jun-2023 01:40
From: Anonymous Member
Subject: Standards / Regulations - Brazil
This message was posted by a user wishing to remain anonymous
We are a medical device company and have Class II products distributed in Brazil by our distributors. There has been changes in the RDC's that are very confusing when looking them up on the website. Please could someone post a list of the current standards/regulations for Brazil and which ones have been superseded. The list will be very useful for our upcoming audit. Also it would be greatly appreciated if there is a consultant specifically for Brazil whom may be able address this. We are well aware of ANVISA 665/2022 which is the most current but would also like to know the full name of the standards/regulations. Many thanks